M2Bio Sciences, Inc.

M2Bio Sciences, Inc.

Alternative Medicine

At the forefront of medicinal cannabis and mushrooms - Trading on the OTC: $MRES

About us

M2Bio Sciences, Inc. is a nutraceutical biotechnology company that researches, develops and commercialises a range of CBD-based products under the Dr. AnnaRx™, Medspresso™ and Liviana™ brands. In addition, its new wholly-owned division, is researching and developing indications for psilocybin new therapies that will help patients who suffer from mental illness, Alzheimer's and Parkinson's. Our vision is to improve people’s quality of life by unleashing the full potential of medicinal cannabis and mushrooms. Our mission is to advance botanical-based medicine to the forefront. From seed to shelf and spore to store, we are driven by a passion for medicine and science. We live by the values of: Quality. Excellence. Science. Traceability. Accountability. Humility. M2Bio is listed and traded on the Over The Counter Bulletin Board of NASDAQ under the trading symbol “$MRES”. The global market for legal cannabis is according to Euromonitor International anticipated to grow 1,283 percent in value of sales, in the next seven years, from US$12B to US$166B at a CAGR of 45.5 percent (2018-2025), subject to increased legalisation.

Website
https://m2bio.co
Industry
Alternative Medicine
Company size
11-50 employees
Headquarters
Cape Town
Type
Public Company
Founded
2018
Specialties
Cannabis, Cannabidiol, Medicine, Biotechnology, Psilocybin, Medicinal Mushrooms, Health , Neuroscience, and Alternative Medicine

Locations

Employees at M2Bio Sciences, Inc.

Updates

  • View organization page for M2Bio Sciences, Inc., graphic

    2,322 followers

    𝑨 𝑵𝒆𝒘 𝑾𝒆𝒂𝒑𝒐𝒏 𝑨𝒈𝒂𝒊𝒏𝒔𝒕 𝑨𝒏𝒐𝒓𝒆𝒙𝒊𝒂? 𝑺𝒕𝒖𝒅𝒚 𝑬𝒙𝒑𝒍𝒐𝒓𝒆𝒔 𝑷𝒔𝒊𝒍𝒐𝒄𝒚𝒃𝒊𝒏'𝒔 𝑷𝒐𝒕𝒆𝒏𝒕𝒊𝒂𝒍 New research suggests psilocybin, the compound found in magic mushrooms, may offer a breakthrough in treating anorexia nervosa (AN). 𝘏𝘦𝘳𝘦'𝘴 𝘸𝘩𝘺 𝘵𝘩𝘪𝘴 𝘪𝘴 𝘪𝘮𝘱𝘰𝘳𝘵𝘢𝘯𝘵: AN is a Serious Condition: Characterized by severe weight loss and rigid eating patterns, AN has one of the highest mortality rates among psychiatric disorders. Current Treatments Fall Short: Traditional medications like SSRIs often prove ineffective in underweight patients with AN. Psilocybin's Potential: This study in rats demonstrates psilocybin's ability to improve cognitive flexibility and body weight maintenance, suggesting a new approach for managing the cognitive aspects of AN. 𝘞𝘩𝘢𝘵'𝘴 𝘨𝘳𝘰𝘶𝘯𝘥𝘣𝘳𝘦𝘢𝘬𝘪𝘯𝘨? Mechanism of Action: Researchers pinpointed a specific brain mechanism by which psilocybin works, paving the way for targeted therapies to address rigid thinking patterns associated with AN. 𝘐𝘮𝘱𝘰𝘳𝘵𝘢𝘯𝘵 𝘊𝘢𝘷𝘦𝘢𝘵𝘴: Animal Model: While promising, these results come from an animal study, and human trials are crucial for confirmation. Safety & Long-Term Effects: More research is needed to evaluate the safety and long-term effects of psilocybin use in humans with AN. Overall, this study offers a glimmer of hope for developing more effective treatments for anorexia.  As research progresses, we'll gain a clearer picture of psilocybin's therapeutic potential in this debilitating condition. Link to study: https://lnkd.in/dwFVRwdb Link to original article: https://lnkd.in/ezjaiKTJ #MentalHealth #Psychedelics #EatingDisorders #ANResearch #BreakthroughTreatment Dr. X

    Psilocybin restrains activity-based anorexia in female rats by enhancing cognitive flexibility: contributions from 5-HT1A and 5-HT2A receptor mechanisms - Molecular Psychiatry

    Psilocybin restrains activity-based anorexia in female rats by enhancing cognitive flexibility: contributions from 5-HT1A and 5-HT2A receptor mechanisms - Molecular Psychiatry

    nature.com

  • View organization page for M2Bio Sciences, Inc., graphic

    2,322 followers

    𝑷𝒔𝒚𝒄𝒉𝒆𝒅𝒆𝒍𝒊𝒄 𝑻𝒓𝒆𝒂𝒕𝒎𝒆𝒏𝒕𝒔 𝒇𝒐𝒓 𝑴𝒆𝒏𝒕𝒂𝒍 𝑯𝒆𝒂𝒍𝒕𝒉: 𝑬𝒖𝒓𝒐𝒑𝒆 𝑱𝒐𝒊𝒏𝒔 𝒕𝒉𝒆 𝑬𝒙𝒑𝒍𝒐𝒓𝒂𝒕𝒊𝒐𝒏 Exciting news for mental health research! The European Medicines Agency (EMA) is exploring the potential of psychedelic compounds to treat conditions like depression, addiction, and PTSD. 𝐇𝐞𝐫𝐞'𝐬 𝐰𝐡𝐲 𝐭𝐡𝐢𝐬 𝐢𝐬 𝐚 𝐛𝐢𝐠 𝐝𝐞𝐚𝐥: Filling the Gap: Traditional treatments haven't kept pace with rising mental health issues. Psychedelics could offer a new approach. Learning from the US: The EMA is inspired by the US's "breakthrough therapy" designation for LSD in treating anxiety. Research is Key: High-quality studies are crucial to understand the safety and effectiveness of these therapies. Setting the Stage: The EMA acknowledges "set and setting" (patient mindset and treatment environment) as important factors for success. Challenges Remain: Finding effective placebos for psychedelic trials is a hurdle to overcome. Overall, this is a positive step towards exploring new avenues for mental health treatment.  I'll keep you posted on further developments! #mentalhealth #psychedelics #research #breakthroughtherapies Link to original article: https://lnkd.in/drGSVBSg Dr. X

    EMA Embarks on Psychedelic Trip

    EMA Embarks on Psychedelic Trip

    medscape.com

  • M2Bio Sciences, Inc. reposted this

    View organization page for Liviana® Health, graphic

    148 followers

    We should ask ourselves: would we accept a fake banknote and attempt to use it as legal tender? Would we be happy if we paid for a can of pickled artichokes and opened it up to find potatoes in it? Yet ordinary people buy fake honey every day, while the time-honoured art of beekeeping is under threat. The term “fake honey”, is typically used to describe small amounts of real honey that have been bulked up with cheap sugars and syrups. Often these syrups are derived from corn and rice. Nestled between the Swartberg and Outeniqua mountains, Liviana™ range of honeys have origins as beautiful and pure as its flavour, derived from blossoms and native flora. Nothing but pure honey guaranteed. Make the healthier choices for your family today: https://lnkd.in/duK7M5pa #liviana #honey #fakehoney #healthyfood #healthyeating #realhoney #foodstagram

  • M2Bio Sciences, Inc. reposted this

    View organization page for Liviana® Health, graphic

    148 followers

    We’ve got some exciting news to officially share with our fellow foodies!! ✨🥙🥑🥕 As part of the Tasters Club, you’ll have the opportunity to be among the first to sample our latest products before they hit the shelves. Every time we launch a new product, or even when we want to share a sample of one of our existing favourites, we’ll be selecting a few lucky subscribers who have submitted their details to receive a special taster! We value your opinion and would love to see you tasting and reviewing the product, so let’s get you in on all the foodie action, just a click away: https://lnkd.in/dGt_6fa6 #liviana #tastersclub #foodclub #rewardsclub #food #healthyfood #healthylifestyle

  • View organization page for M2Bio Sciences, Inc., graphic

    2,322 followers

    𝑪𝒐𝒇𝒇𝒆𝒆 & 𝒀𝒐𝒖𝒓 𝑯𝒆𝒂𝒓𝒕: 𝑨 𝑩𝒓𝒆𝒂𝒌𝒅𝒐𝒘𝒏 𝒐𝒇 𝒕𝒉𝒆 𝑼𝑲 𝑩𝒊𝒐𝒃𝒂𝒏𝒌 𝑺𝒕𝒖𝒅𝒚 ☕️🫀 Researchers analyzed data from over 449,000 UK Biobank participants to see how different coffee types affect heart health and mortality. 𝑻𝒉𝒆 𝑮𝒐𝒐𝒅 𝑵𝒆𝒘𝒔: All types of coffee (decaf, ground, and instant) were linked to a lower risk of heart disease and death compared to non-coffee drinkers. 𝑻𝒉𝒆 𝑺𝒘𝒆𝒆𝒕 𝑺𝒑𝒐𝒕: The study suggests a "sweet spot" for coffee consumption – around 2-3 cups per day for all types offered the most significant benefits. 𝑨 𝑹𝒉𝒚𝒕𝒉𝒎 & 𝑩𝒍𝒖𝒆𝒔 𝑵𝒐𝒕𝒆: Interestingly, ground and instant coffee (but not decaf) were associated with a lower risk of arrhythmias (irregular heartbeats) at moderate intake (1-5 cups/day). This warrants further investigation. Overall, this is promising! 𝑴𝒐𝒅𝒆𝒓𝒂𝒕𝒆 𝒄𝒐𝒇𝒇𝒆𝒆 𝒄𝒐𝒏𝒔𝒖𝒎𝒑𝒕𝒊𝒐𝒏 could be part of a heart-healthy lifestyle. 𝑯𝒐𝒘𝒆𝒗𝒆𝒓, 𝒓𝒆𝒎𝒆𝒎𝒃𝒆𝒓: 𝑪𝒐𝒓𝒓𝒆𝒍𝒂𝒕𝒊𝒐𝒏 ≠ 𝑪𝒂𝒖𝒔𝒂𝒕𝒊𝒐𝒏: This study can not establish direct causation. 𝑰𝒏𝒅𝒊𝒗𝒊𝒅𝒖𝒂𝒍 𝑵𝒆𝒆𝒅𝒔 𝑴𝒂𝒕𝒕𝒆𝒓: Some are more sensitive to caffeine and may experience anxiety or sleep issues. Listen to your body! 𝑸𝒖𝒂𝒍𝒊𝒕𝒚 𝑪𝒐𝒖𝒏𝒕𝒔: Sugary coffee drinks and excessive cream can negate potential benefits. Opt for black coffee or minimal additions. 𝑻𝒉𝒆 𝑻𝒂𝒌𝒆𝒂𝒘𝒂𝒚: Enjoy your coffee in moderation, but maintain a balanced diet and regular exercise for a truly healthy heart. Read the full study: https://lnkd.in/djSRB24r 𝑺𝒕𝒂𝒚 𝒄𝒖𝒓𝒊𝒐𝒖𝒔, 𝒔𝒕𝒂𝒚 𝒉𝒆𝒂𝒍𝒕𝒉𝒚! #coffee #hearthealth #ukbiobank #preventivemedicine

    The impact of coffee subtypes on incident cardiovascular disease, arrhythmias, and mortality: long-term outcomes from the UK Biobank - PubMed

    The impact of coffee subtypes on incident cardiovascular disease, arrhythmias, and mortality: long-term outcomes from the UK Biobank - PubMed

    pubmed.ncbi.nlm.nih.gov

Similar pages

Browse jobs

Funding

M2Bio Sciences, Inc. 1 total round

Last Round

Post IPO equity

US$ 450.0K

See more info on crunchbase